China Kangtai Cactus Biotech Inc. (OTCBB: CKGT) (the "Company"), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that preliminary samples of its new "Tai Shan Sheng Chao" cigarette have been co-developed by China Tobacco Shandong and China Kangtai Cactus. The new cigarette products primarily target the Russian market.

The new cigarette is produced by Shandong Jinan Tobacco Company, a subsidiary of China Tobacco Shandong. China Kangtai has modified the ingredients of its original cigarette to develop a new cigarette that accommodates the unique tastes and fragrance preference of Russian cigarette smokers. The new cigarette is blended to taste similar to State Express 555 and Marlboro cigarettes.

China Kangtai Cactus CEO Mr. Jinjiang Wang said, "The development of this new cigarette is a significant milestone achievement for our company. We are confident that this new cigarette will greatly increase our future sales and profit margin for our shareholders."

The company said it is currently engaging negotiation talks with potential distributors regarding the distribution rights in Russia.

About "Tai Shan Sheng Chao" Cigarette

The "Tai Shan" cigarette, which is produced by China Tobacco Shandong, is a registered brand in China. "Sheng Chao," which was developed by China Kangtai Cactus, is a cactus-based cigarette with additional herbs and some tobacco that targets consumers who prefer low-nicotine cigarettes. The company signed a cooperation agreement with China Tobacco Shandong at the end of 2010 to launch the "Tai Shan Sheng Chao" cigarette and began full production of the "Tai Shan Sheng Chao" cigarette in February 2011. The company currently has trial sales in Shandong province. China Kangtai Cactus is the first publicly held company to sign a joint manufacturing agreement with a government-owned cigarette manufacturer. Shandong Jinan Tobacco Company is one of the primary tobacco manufacturers in China with revenue of RMB 5 billion (approximately $770 million) in 2010.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

China Kangtai's online investor kit, including an investment profile, press releases, current price quotes, stock charts and more is available at http://www.hawkassociates.com/profile/ckgt.cfm. To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/.

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For China Kangtai Cactus Biotech Inc.
Investor Contacts:
Hawk Associates
Frank Hawkins, 305-451-1888
or
Amy Lin, 305-451-1888
kangtai@hawkassociates.com